Topics tagged FDA

Topic	Replies	Views	Activity
CHPA's response to the Control of Nitrosamine Impurities in Human Drugs rev.2 Guidance, Documents, Resources FDA	1	466	January 2, 2025
Requirement after reformulation of existing approved drug product for Europe New Scientific Knowledge & Development EMA , FDA	12	588	November 12, 2024
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program New Scientific Knowledge & Development Packaging , FDA	6	669	October 2, 2024
🇺🇸 FDA - Updated information on recommended AI for NDSRIs (23/Feb/2024) - Tables 2 & 3 Limits of Nitrosamines Limits , FDA , NDSRI	16	4752	July 28, 2024
Pharmaceutical industry wants FDA to extend deadline for testing novel nitrosamines Nitrosamines in the News FDA , NDSRI	3	1219	July 21, 2023
AI Limit for Nitroso Nebivolol Limits of Nitrosamines FDA , Drug_Substance_APIs , Storage_Stability , Manufacturing , Live-Conversations	11	3030	April 3, 2024
Nitrosamine requirements for probiotics Guidance, Documents, Resources FDA	4	442	February 12, 2024
N-nitroso Vonoprazan AI 96 ng/day- FDA Limits of Nitrosamines FDA	5	4455	January 29, 2024
A quick (dumb) question Limits of Nitrosamines FDA , Excipients	10	1554	January 22, 2024
AI for NDSRIs with positive EAT and/or in-vivo mutagenicity study - FDA position? Limits of Nitrosamines Limits , FDA , NDSRI	2	755	November 9, 2023
N-Nitroso desmethyl bedaquiline Limits of Nitrosamines FDA	0	719	October 6, 2023
Total impurities limit if more than one nitrosamine impurities are observed in product Limits of Nitrosamines Manufacturing , NDSRI , Drug_Substance_APIs , FDA , Live-Conversations	3	783	August 14, 2023
FDA Workshop: Mitigation Strategies for Nitrosamine Drug Substance Related Impurities Events / Workshops / Webinars Excipients , FDA , NDSRI , Drug_Substance_APIs , Manufacturing	11	4341	July 27, 2023
Fiscal Year (FY) 2023 Generic Drug Science and Research Initiatives Public Workshop May 11-12, 2023 Events / Workshops / Webinars FDA	3	676	June 15, 2023
FDA/HESI Collaborative Roadmap: Advancing Hazard and Risk Assessment of Nitrosamine Impurities in Pharmaceuticals Limits of Nitrosamines NDSRI , ames , FDA , Drug_Substance_APIs	2	970	June 5, 2023
N-nitroso Des-methyl Dapoxetine Limits of Nitrosamines FDA , Manufacturing , Drug_Substance_APIs	12	1522	May 31, 2023
FDA Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays Limits of Nitrosamines FDA , NDSRI , ames , NDSRIs	1	1707	May 24, 2023
Florida District Court dismissed claims that "Ranitidine-NDMA caused cancer -" because of "unreliable methodologies" and lacked "science-based standards" Nitrosamines in the News FDA	0	380	December 13, 2022
Harmonization of AI for NDSRIs with insufficient carcinogenic data Limits of Nitrosamines FDA	5	1270	July 14, 2022
FDA - Generic Drug Forum 2022 (Nitrosamine update) 📺 Events / Workshops / Webinars FDA	9	1241	April 27, 2022